Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs (Q3013989): Difference between revisions

@@ Property / DOI @@
-.1111/j.1541-0420.2010.01471.x
@@ Property / DOI: 10.1111/j.1541-0420.2010.01471.x / rank @@
-Normal rank
@@ Property / Wikidata QID @@
+Q35797245
@@ Property / Wikidata QID: Q35797245 / rank @@
+Normal rank
@@ Property / MaRDI profile type @@
+Publication
@@ Property / MaRDI profile type: Publication / rank @@
+Normal rank
@@ Property / OpenAlex ID @@
+W2161784456
@@ Property / OpenAlex ID: W2161784456 / rank @@
+Normal rank
@@ Property / arXiv ID @@
+.1223
@@ Property / arXiv ID: 1108.1223 / rank @@
+Normal rank
@@ Property / cites work @@
+Approximate dynamic programming and its applications to the design of Phase I cancer trials
+Normal rank
@@ Property / cites work @@
+Coherence principles in dose-finding studies
@@ Property / cites work: Coherence principles in dose-finding studies / rank @@
+Normal rank
@@ Property / cites work @@
+Optimal designs for a class of nonlinear regression models
+Normal rank
@@ Property / cites work @@
+Adaptive designs for dose-finding based on efficacy-toxicity response
+Normal rank
@@ Property / cites work @@
+Adaptive designs for selecting drug combinations based on efficacy-toxicity response
+Normal rank
@@ Property / cites work @@
+Bayesian Optimal Designs for Phase I Clinical Trials
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Penalized optimal designs for dose-finding
@@ Property / cites work: Penalized optimal designs for dose-finding / rank @@
+Normal rank
@@ Property / cites work @@
+Q4828566
@@ Property / cites work: Q4828566 / rank @@
+Normal rank
@@ Property / cites work @@
+Q4235027
@@ Property / cites work: Q4235027 / rank @@
+Normal rank
@@ Property / cites work @@
+Dose-Finding Based on Efficacy-Toxicity Trade-Offs
+Normal rank
@@ Property / cites work @@
+Optimal Bayesian-feasible dose escalation for cancer phase I trials
+Normal rank
@@ Property / DOI @@
+.1111/J.1541-0420.2010.01471.X
@@ Property / DOI: 10.1111/J.1541-0420.2010.01471.X / rank @@
+Normal rank
@@ links / mardi / name / links / mardi / name @@
+Publication:3013989